Evidence map›Paper›PMID 31897219›Full record

ArticleOncology letters2020

A gene-expression-based test can outperform bap1 and

Greta Alì, Rossella Bruno, Anello Marcello Poma, Agnese Proietti, Stefano Ricci, Antonio Chella, Franca Melfi, Marcello Carlo Ambrogi, Marco Lucchi, Gabriella Fontanini

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncology letters, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Greta AlìUnit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Rossella BrunoUnit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Anello Marcello PomaDepartment of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, I-56126 Tuscany, Italy.
Agnese ProiettiUnit of Pathological Anatomy, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Stefano RicciDepartment of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, I-56126 Tuscany, Italy.
Antonio ChellaUnit of Pneumology, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Franca MelfiUnit of Minimally Invasive and Robotic Thoracic Surgery, Robotic Multispeciality Center for Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Marcello Carlo AmbrogiUnit of Thoracic Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Marco LucchiUnit of Thoracic Surgery, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Gabriella FontaniniProgram of Pleuropulmonary Pathology, Azienda Ospedaliero Universitaria Pisana, AOUP, Pisa, I-56126 Tuscany, Italy.
Azienda Ospedaliera Universitaria Pisana · ITUniversity of Pisa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The demonstration of tissue invasion by histology is an essential criterion for the differential diagnosis of benign and malignant mesothelial proliferations. When tissue invasion cannot be identified, the use of ancillary tests is sometimes necessary. Among investigated markers, the loss of BRCA1 associated protein 1 (BAP1) protein expression and the homozygous deletion of

Indexed as

BRCA1 associated protein 1 immunohistochemistrymalignant pleural mesotheliomamesothelial hyperplasiap16 fluorescent in situ hybridization

Identifiers

PMID31897219
PMCPMC6924193
OpenAlexW2993236813

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.